立即和延迟皮肤过敏反应对帕克利塔塞尔的预测因素
Megan H Trager1, Alyce M Kuo2, Stephen W Dusza2
1Department of Dermatology, Columbia University, New York, NY, USA.
Archives of dermatological research
|October 9, 2024
概括
对常见的癌症药物paclitaxel的过敏反应与年轻年龄,种族和过敏史有关. 经历了立即反应的患者更容易出现延迟的皮肤反应,指导治疗选择.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
- 临床药理学 临床药理学
背景情况:
- 帕克利塔塞尔是乳腺,卵巢和肺癌的重要化疗剂.
- 过敏反应 (HSR) 经常限制了帕克利塔塞尔的临床效用.
- 了解HSR的风险因素对于患者管理至关重要.
研究的目的:
- 为了确定与帕克利塔塞尔的立即和延迟过敏反应相关的临床因素.
- 描述乳腺癌患者延迟过敏反应的特征.
- 为了告知关于帕克利塔克塞尔或纳布-帕克利塔克塞尔治疗的临床决策.
主要方法:
- 纪念斯隆·凯特林癌症中心对12,274名用帕克利塔塞尔治疗的患者进行了回顾性图表审查.
- 分析立即和延迟的过敏反应,包括皮肤表现.
- 统计评估风险因素,如年龄,种族和过敏史.
主要成果:
- 11.9%的患者立即出现过敏反应.
- 年轻的年龄,特定的种族和过敏史是立即HSRs的危险因素.
- 患有即时HSR的患者患有延迟皮肤反应的可能性增加 (OR=1.80).
- 黄斑发疹和疹是常见的延迟反应,与亚洲种族和过敏史有关.
结论:
- 年轻的年龄,种族和过敏史是立即发生帕克利塔克塞尔过敏的重要危险因素.
- 立即的HSR预测了随后延迟皮肤反应的更高风险.
- 识别这些危险因素有助于选择适当的化疗,可能有利于NAB-PACLITAXEL或考虑脱敏.
更多相关视频
09:39Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
Published on: February 13, 2018
9.5K
09:38Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery
Published on: April 14, 2016
12.6K
相关概念视频
Hypersensitivities
536
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
536
Allergic Drug Reactions
817
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
817
